One year after the publication of the results of the Women's Health Initiative (WHI) randomized trial, which received significant media attention, the data on the relationship between menopausal hormone therapy (MHT) and breast cancer risk have been supplemented by the findings of a large prospective cohort study, the Million Women Study (MWS). The authors of the article discuss the results of the Million Women Study.